Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Jurmeister, P; Leitheiser, M; Wolkenstein, P; Klauschen, F; Capper, D; Brcic, L.
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas.
Lung Cancer. 2022; 170:105-113 Doi: 10.1016/j.lungcan.2022.06.008
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Brcic Luka
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
OBJECTIVES: Our goal was to evaluate the diagnostic value of DNA methylation analysis in combination with machine learning to differentiate pleural mesothelioma (PM) from important histopathological mimics. MATERIAL AND METHODS: DNA methylation data of PM, lung adenocarcinomas, lung squamous cell carcinomas and chronic pleuritis was used to train a random forest as well as a support vector machine. These classifiers were validated using an independent validation cohort including pleural carcinosis and pleomorphic variants of lung adeno- and squamous cell carcinomas. Furthermore, we performed differential methylation analysis and used a deconvolution method to estimate the composition of the tumor microenvironment. RESULTS: T-distributed stochastic neighbor embedding clearly separated PM from lung adenocarcinomas and squamous cell carcinomas, but there was a considerable overlap between chronic pleuritis specimens and PM with low tumor cell content. In a nested cross validation on the training cohort, both machine learning algorithms achieved the same accuracies (94.8%). On the validation cohort, we observed high accuracies for the support vector machine (97.8%) while the random forest performed considerably worse (89.5%), especially in distinguishing PM from chronic pleuritis. Differential methylation analysis revealed promoter hypermethylation in PM specimens, including the tumor suppressor genes BCL11B, EBF1, FOXA1, and WNK2. Deconvolution of the stromal and immune cell composition revealed higher rates of regulatory T-cells and endothelial cells in tumor specimens and a heterogenous inflammation including macrophages, B-cells and natural killer cells in chronic pleuritis. CONCLUSION: DNA methylation in combination with machine learning classifiers is a promising tool to reliably differentiate PM from chronic pleuritis and lung cancer, including pleomorphic carcinomas. Furthermore, our study highlights new candidate genes for PM carcinogenesis and shows that deconvolution of DNA methylation data can provide reasonable insights into the composition of the tumor microenvironment.
Find related publications in this database (using NLM MeSH Indexing)
Adenocarcinoma of Lung - genetics
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Squamous Cell - genetics
DNA Methylation - administration & dosage
Endothelial Cells - pathology
Humans - administration & dosage
Lung - pathology
Lung Neoplasms - diagnosis, genetics, pathology
Machine Learning - administration & dosage
Mesothelioma - diagnosis, genetics, pathology
Mesothelioma, Malignant - genetics
Pleural Neoplasms - diagnosis, genetics, pathology
Pleurisy - diagnosis, genetics
Protein Serine-Threonine Kinases - administration & dosage
Tumor Microenvironment - genetics

Find related publications in this database (Keywords)
Pleuralmesothelioma
Chronicpleuritis
Pleuralcarcinosis
Machinelearning
DNAmethylation
© Med Uni Graz • Imprint